ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

Researchers Examine Lifetime Risk of Total Hip Replacements

Arthritis Care & Research  |  November 6, 2017

Total hip replacement (THR) surgery is an effective way to reduce pain and improve function in people with advanced hip osteoarthritis (OA). In light of aging populations, there’s a need to use contemporary, population-level data to plan for future service provision. In a study designed to compare THR data across countries, researchers demonstrated a significant increase in the overall use of and lifetime risk for THR from 2003 to 2013. Women consistently had a higher lifetime risk of surgery than men in all five countries studied, whereas men in all five countries demonstrated a significant increase in lifetime risk for THR over time…

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:Arthritis Care & Researchhiphip arthroplastyosteoarthritis (OA)surgerytotal hip replacement

Obamacare Whiplash Leaves States, Insurers with Dueling Price Plans

Caroline Humer  |  October 22, 2017

NEW YORK (Reuters)—President Donald Trump’s reversals in the past week on maintaining Obamacare subsidies to insurers are sowing new confusion over what kind of health insurance will be available to consumers, and at what price, when enrollment for 2018 begins in two weeks. Trump said last week his administration would stop paying billions of dollars…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Affordable Care Act (ACA)Health InsuranceObamacare

The ARHP Helps Rheumatology Professionals Avoid Information Overload

Erin Latimer Meadows  |  October 18, 2017

In a world where some information is good, more information is better and information overload is a way of life, Carole Dodge, BS, OTR, CHT—a practicing occupational therapist at the University of Michigan—considers the ARHP her professional block and tackle. “ARHP helps me sift through a lot of information and get it to a digestible…

Filed under:Practice Support Tagged with:2017 ACR/ARHP Annual MeetingAdvocacyAssociation of Rheumatology Professionals (ARP)EducationHealthcareinformationLegislationNetworkingpatient carereformrheumatologistrheumatology health professionals

Accelerating Medicines Partnership Shares Its Progress on RA/Lupus Network

Lara C. Pullen, PhD  |  October 17, 2017

CHICAGO—“Why do so many drugs fail in clinical trials?” asked Michael Brenner, MD, chief of rheumatology, immunology and allergy at Brigham and Women’s Hospital in Boston. This question, previously posed by Francis Collins, MD, PhD, director of the National Institutes of Health, prompted a discussion among scientists and stakeholders in the pharmaceutical industry. The conversation…

Filed under:ConditionsMeeting ReportsResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:Accelerating Medicines PartnershipFederation of Clinical Immunology SocietiesFOCIS 2017Lupusmeeting reportsRAResearchRheumatic DiseaseRheumatoid arthritisrheumatologysingle-cell disease"SLESystemic lupus erythematosusTreatment

Sequential Therapy May Reduce Hip Fracture Risk; Plus New Biosimilar Available in Canada

Michele B. Kaufman, PharmD, BCGP  |  September 27, 2017

Patients who receive abaloparatide and switch to alendronate have a statistically significant reduction in fracture risk through 3.5 years, according to a new study…

Filed under:Biologics/DMARDsDrug Updates Tagged with:abaloparatidealendronateBiologics & Biosimilarsetanerceptetanercept-szzsFractureshiphip fracturehip fracture risk

Alendronate Decreases Hip Fracture Risk in Older Patients Using Oral Prednisolone

Lara C. Pullen, PhD  |  August 21, 2017

New research found that older patients on prednisolone who are also treated with alendronate experience a significantly lower risk of hip fracture. Alendronate use was also associated with a lower risk of death…

Filed under:Conditions Tagged with:alendronateelderlyFractureship fracturehip fracture riskprednisolone

Overlooking HIPAA Risks Can Lead to Costly Breach

From the College  |  August 16, 2017

Is your office at risk? Are all your business associate agreements (BAAs) in place, and is your office HIPAA compliant? As promised, and as part of its continued efforts to assess and enforce compliance with the HIPAA Privacy, Security and Breach Notification Rules, the Health and Human Services (HHS) Office for Civil Rights (OCR) continues…

Filed under:From the CollegeLegal UpdatesPractice Support Tagged with:electronic protected health information (ePHI)healthcare cybersecurityHIPAA auditsHIPAA PrivacyOffice for Civil Rights (OCR)Security and Breach Notification Rules

Effectiveness of Retinoic Acid, Hydroxychloroquine Examined for Hand OA

Lindsey MacFarlane, MD, MPH  |  August 13, 2017

The Osteoarthritis Research Society International (OARSI) held the 2017 OARSI World Congress in Las Vegas, April 27–30. Below, we report on two of the sessions held. Retinoic Acid & Hand Osteoarthritis Retinoic acid is a vitamin A derivative and hormonal signaling molecule with a role in cartilage and skeletal development. Retinoic acid has complex function,…

Filed under:ConditionsMeeting ReportsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:2017 OARSI World Congresshand osteoarthritisHYDROXYCHLOROQUINEOsteoarthritis Research Society InternationalResearchretinoic acidrheumatologystudiessymptomsTreatment

iQoncept/shutterstock.com

The ARHP Promotes Interdisciplinary Approach to Rheumatology Patient Care

Marie D. Westby, PT, PhD, & Afton L. Hassett, PsyD  |  August 13, 2017

Editor’s note: The new Pillar Talk column is developed by the ARHP Executive Committee in an effort to share information about ongoing activities related to our four pillars: Education, Practice, Research and Advocacy. The ARHP Practice Committee is committed to addressing the current needs and evolving practice opportunities for health professionals working in rheumatology. A…

Filed under:Interprofessional PerspectivePractice SupportProfessional TopicsWorkforce Tagged with:ARP Practice CommitteeAssociation of Rheumatology Professionals (ARP)interdisciplinarypatient carePractice Managementrheumatologistrheumatologyshortage

Glucosamine Supplements Don’t Help Knee or Hip Arthritis Pain

Carolyn Crist  |  August 10, 2017

(Reuters Health)—Oral glucosamine has no more effect than placebo on joint pain, according to a new meta-analysis. The analysis of randomized controlled trials from which data have been made public found that at both three-month and 24-month follow-up points, the supplement had no effect on either hip or knee pain from arthritis. Even sub-groups, such…

Filed under:Drug Updates Tagged with:glucosamine supplementsjoint pain cureoral glucosamineOsteoarthritis Research Society InternationalU.S. National Institute for Health and Care Excellence

  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 336
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences